Background: Limited evidence exists to create institutional admission criteria guidelines for febrile sickle cell patients. In addition, evidence is lacking to understand readmission rates for febrile sickle cell patients discharged from the emergency department (ED) or hospital.
INTRODUCTION
Infants and toddlers with sickle cell anemia (SCA) are at high risk for morbidity and mortality from infection by encapsulated bacteria, especially Streptococcus pneumoniae. 1, 2 With the benefit of penicillin prophylaxis and development of efficacious vaccines against strains of pneumococcus, bacteremia and premature mortality incidence has markedly decreased in children with SCA. [3] [4] [5] [6] Nonetheless, patients with SCA remain at high risk for infection and require an immediate evaluation of each febrile episode that includes blood cultures and initiation of empiric antibiotics. 7 This concern for infection-related morbidity and mortality directs hospitalization of many febrile pediatric patients with SCA until blood cultures are negative for bacteria.
Abbreviations: CXR, chest X-ray; ED, emergency department; SCA, sickle cell anemia; WBC, white blood cell Historically, decision to admit patients with SCA for a febrile episode were based on physician acumen, age of patient, maximum temperature, or change in hematologic laboratory values from baseline. 8 In an attempt to validate criteria for admission for febrile SCA patients, a randomized trial of outpatient therapy versus inpatient therapy was conducted among "low-risk" participants. 9 Patients were excluded from randomization in this study if they met "high-risk" criteria which included (1) seriously ill appearing, (2) abnormal blood pressure or poor capillary refill, (3) temperature > 40 • C, (4) white blood cell (WBC) >30 or <5 × 10 9 /L, (5) platelet count <100 × 10 9 /L, (6) history of pneumococcal infection, or (7) other SCA complications requiring hospitalization. Among these "high-risk" participants who were not randomized, 8% of febrile events were associated with bacteremia, while none of the "low-risk" randomized participants developed bacteremia. A modified version of this "high-risk" definition was also evaluated in a large retrospective review, which provided additional evidence that "lower risk" patients as compared to the "high-risk" patients presenting to the emergency department (ED) can be safely managed in the outpatient setting. 10 Recently, the 2014 NIH expert panel on the management of sickle cell disease suggests that all patients with SCA with a temperature ≥103.1 • F (39.5 • C) and who are ill appearing should be admitted to the hospital for observation and intravenous antibiotics. 7 Importantly, this statement from the NIH reflects a consensus opinion of their expert panel due to a lack of highquality literature in this field. These two risk definitions differ in their recommendations for admission (Wilimas "high-risk" fever admission criteria 9 : including temperature of ≥ 40 • C, ill appearance, abnormal vital signs or laboratory results vs NIH expert panel fever admission criteria 7 : 39.5 • C and ill appearance) and therefore warrant further investigation regarding outcomes for febrile SCA patients.
As economic stressors are placed on health care systems to ensure appropriate admission criteria and length of hospitalization, it is vital that additional research explore outcomes of febrile SCA patients and attempt to more accurately define "risk" categories for admission and appropriate length of hospitalization for patients that have been admitted for fever. The current study was undertaken to address the limitations in the field of having two differing admission criteria for febrile SCA events. Accordingly, we used retrospectively abstracted data from a single institution in patients with SCA who are presented to the ED with fever over a 16-year period to compare the level of concordance between the two published admission criteria and, if needed, to consider modification of these criteria with the eventual goal of developing novel admission criteria. 7,9 Second, we evaluated the impact of hospitalization of febrile patients on preventing new SCA complications by comparing 14-day readmission rates among febrile patients initially discharged from the ED versus febrile patients admitted to the hospital and discharged within 72 h. This study can inform decision making for admission criteria and hospitalization length in febrile pediatric patients with SCA.
METHODS

Study population
We conducted a retrospective study of the electronic medical records of patients with SCA (HbSS or SB 0 thalassemia) who were <18 years old and presented to the Children's of Alabama ED with a temperature ≥101.0 • F from October 1999 to June 2016. This study was approved by the University of Alabama at Birmingham Institutional Review Board. As the primary objective of this study was to determine outcomes of fever in the ED at Children's of Alabama, this study excluded patients who were presented afebrile to our outpatient clinic but developed fever in our clinic, most often during a blood transfusion through a central venous line. Second, we excluded patients from our rural-based satellite clinics that initially presented to a local ED with fever and subsequently transferred to our inpatient unit. 11 Third, we excluded patients with a subjective fever at home and a temperature <101.0 • F throughout their ED visit. Finally, we excluded afebrile patients admitted for other sickle cell complications but developed fever during an admission.
Laboratory and clinical investigations
The ED standard of care for sickle cell patients presenting to the ED with a temperature ≥101.0 • F is to obtain a complete blood count and blood cultures prior to receiving a dose of antibiotics; a chest X-ray (CXR) is obtained for febrile patients with any concern for a respiratory illness. We abstracted details regarding age, vital signs, peripheral blood counts, and the radiologist's interpretation of the CXR. We reviewed ED provider physical examination or clinical statements to identify patients who were clinically ill. The statements categorized as "ill" in this study included "ill" (n = 40), "uncomfortable" (n = 5), "chills" (n = 3), "lethargic" (n = 1), or "seizure" (n = 1). Finally, we recorded all blood culture results obtained during the ED visit and hospitalization to identify cases with bacteremia and time from admission to blood culture positivity. Clinical practice guideline mandates admission for patients with acute chest syndrome; therefore, a priori we decided to exclude 122 patients admitted with fever and an abnormal CXR.
Outcomes
The primary outcomes of interest, bacteremia identified from a blood culture, was categorized as "yes" or "no." We excluded bacteremia cases that were determined to be a contaminant by the inpatient team.
The risk variables for fever admission criteria identified from the literature and extracted for this analysis included temperature (fever categorized from the admission criteria literature as either ≥39.5 • C or ≥40 • C), WBC (abnormal categorized as >30 or <5 × 10 9 /L), and heart rate and blood pressure (tachycardia and hypotension definitions were based on the age-specific 2015 Pediatric Advanced Life Support guidelines). We determined sensitivity, specificity, and positive predictive value for these risk variables for the primary outcome of bacteremia.
We acknowledge that this study represents the experience from a single institution where there has not been a consistent admission practice for febrile SCA events over the 16-year period. However, this heterogeneity in practice has allowed us to examine the bacteremia outcomes using differing risk variables for admission from the literature and explore novel admission criteria. We created a "high-risk" category, using a modified version of the Wilimas definition, defined by having at least one abnormal risk variable (temperature ≥40 • C, tachycardia by age, hypotension, WBC (>30.0 or <5.0 × 10 9 /L)). Second, we created a category for patients that met admission criteria based on the NIH consensus of a temperature ≥ 39.5 • C and ill appearance.
To evaluate new SCD complications that developed in febrile patients, we compared 14-day readmission rates among patients with febrile events either initially discharged from the ED or from the hospital within 72 h of their admission. We made an a priori decision that readmissions after 14 days from the initial presentation to the ED may not be attributable to the initial febrile event. All patients admitted to the hospital received intravenous antibiotics until 48-h cultures were negative; we could not determine if patients discharged from the ED filled an oral antibiotic prescription if it was prescribed by the ED physician. 
TA B L E 1 Laboratory and clinical variables in sickle cell anemia patients with febrile events evaluated in the emergency department
Statistical analysis
Each febrile event was deemed to be an independent event. Descriptive statistics (means/standard deviation) were calculated and compared using t-test. 
RESULTS
We identified 653 febrile events in 155 patients with SCA (HbSS or SB 0 thalassemia) that are presented to the Children's of Alabama ED with fever and a normal CXR. The median number of febrile events per patient was 3 (range, 1-9). Eighty-two (53%) patients were male.
The median age for febrile events was 2 years (range, 0.1-17 years). Clinical and laboratory variables for all febrile events are presented in Table 1 .
All febrile events
Bacteremia was identified in 17 (2.6%) of the 653 febrile events that are presented to the ED (Table 1 ). The positive predictive values, sensitivities, and specificities for bacteremia by categorical variables are presented in Table 2 . Multivariable analysis (Table 3) revealed that "ill-appearing" phenotype was associated with an 8.5-fold increased odds of being diagnosed with bacteremia (95% CI, 2.9-25.3, P < 0.0001). Presence of tachycardia by age was associated with a 3.7-fold increased odds of bacteremia, although this association did not reach statistical significance (P = 0.09). Abnormal white count and abnormal BP were associated with a 2.4-fold odds of bacteremia, the association for these variables also did not reach statistical significance. In Figure 1 , we show the receiver operating characteristics that Table 2 .
We identified pneumococcal bacteremia during six (0.9%) febrile events ( Table 1) and without any pneumococcal bacteremia for initial ED temperature (P = 0.2), age (P = 0.8), heart rate (P = 0.2), systolic blood pressure (P = 0.9), diastolic blood pressure (P = 0.5), hemoglobin (P = 0.5), or platelet count (P = 0.9).
Time to positive blood culture and length of stay
The median time to the first positive blood culture was 18 h (range,
8-85 h). Streptococcus pneumoniae infections were identified at a mean
of 16 h (range 9-24 h) ( Table 4 ). The one patient with a positive blood a Bacteremia (n = 16) with heart rate recorded in EMR; pneumococcal bacteremia (n = 5); febrile admissions (n = 535). b Bacteremia (n = 16) with blood pressure recorded in EMR and five pneumococcal (n = 5); febrile admissions (n = 490). Abbreviation: PPV, positive predictive value; Temp, temperature; CXR, chest X-ray; WBC, white blood cell. The median length of hospitalization among patients admitted with bacteremia was 8.0 days (range, 2-22 days), which was longer than the admission length of febrile events (n = 496) not associated with bacteremia (median: 3 days, P < 0.0001).
TA B L E 2 Bacteremia and pneumococcal bacteremia by risk variables
TA B L E 3 Risk factors associated with bacteremia
Febrile admission events that progressed to acute chest syndrome
We identified 10 patients who were presented to the ED with a fever and a negative CXR on admission who were subsequently identified with an infiltrate on CXR during the hospitalization and diagnosed with ACS. Nine of the 10 patients (90%) required oxygen in the ED and were admitted with a concern for ACS despite having an initial negative CXR. One additional patient did not develop respiratory distress until 42 h of hospitalization and subsequently diagnosed with acute chest syndrome based on a new infiltrate on CXR.
Fourteen-day readmission for patients discharged from ED or within 72 h of initial hospitalization
Despite admitting 78% of the 653 febrile events at our institution, five of 145 patients (3.4%) initially discharged from the ED were subsequently identified with bacteremia and readmitted to the hospital (Supporting Information Table S1 ). We also identified an additional 26 readmission events within 14 days of the initial ED febrile visit (6%) among 287 febrile events discharged from the hospital within 72 h or 140 febrile events initially discharged from the ED. Sixteen readmission events were due to persistent fever, five for pain, two for ACS, and one each for aplastic crisis, croup, and osteomyelitis. No statistically significant difference was noted for the 14-day readmission rate among 14 (4.9%) of 287 hospital discharged febrile events as compared 
Bordetella holmesii 1 85
Staphylococcus aureus 1 2 3
Staphylococcus parasanguinis 1 24
Streptococcus pyogenes 1 1 8
Streptococcus viridans 1 36
to 12 (8.6%) of 140 ED discharged febrile events (P = 0.2). When analyzing the association between initial ED variables and 14-day readmission events, we could not identify statistically significant differences for 14-day readmission between events that required a readmission (n = 26) as compared to events that were not readmitted (n = 401) including age (3.4 vs 3.2 years, P = 0.7), initial ED temperature (39.2 vs 39.2 • C, P = 0.7), initial ED heart rate (142 vs 143 beats per minute, P = 0.9), initial SBP (114 vs 115 mm Hg, P = 0.9), initial DBP (66 vs 63 mm Hg, P = 0.2), or initial WBC (14.6 vs 16.1 × 10 9 /L, P = 0.3).
We identified two patients who were diagnosed with ACS within 14 days of their initial febrile event. One patient was admitted for fever, cough, rhinorrhea, and subsequently diagnosed with influenza. The patient did not have respiratory distress during the hospitalization and was discharged after 48 h of receiving Tamiflu. The patient returned 8 days later with increased work of breathing and was diagnosed with ACS. The second febrile patient was discharge from the ED with fever and a negative CXR but developed ACS 11 days after that febrile event.
DISCUSSION
This study highlights that bacteremia, including pneumococcal bacteremia, is a rare yet serious outcome for febrile SCA patients. We identified a prevalence of bacteremia (17 cases, 2.6%) in febrile children with a normal CXR at our ED that was similar to the 3-4%
identified in the earlier studies of bacteremia but higher than other recent publications. [8] [9] [10] 12 The prevalence of bacteremia in patients with SCA is still higher than the 0.4-0.9% prevalence identified among young pediatric patients presenting to the ED with fever. [13] [14] [15] The modified "high"-risk model (temperature ≥ 40 • C, abnormal WBC, ill appearing, tachycardia by age) had a higher AUC than the NIH model but neither models obtained a value > 0.75. We developed several models and identified two novel admission criteria models with an appropriate AUC; the model using ill appearing, hypotension, and WBC > 30 × 10 9 /L had the highest AUC. In comparison to other models based on WBC, this model with a WBC > 30 × 10 9 /L allows for the lowest hospitalization rate (17% of admissions for febrile ED visits) but also had the lowest sensitivity of 71% among those tested with AUC > 0.75. In comparison, using a WBC > 20 × 10 9 /L increases the sensitivity to 88% but more than doubles the hospitalization rate.
Finally, using a "high-risk" model that includes tachycardia by age would increase the sensitivity to 94% but requires almost 60% of febrile SCA patients to be admitted. Institutions may consider temperature in their fever guidelines but only four (23%) of our bacteremia cases had a temperature >40 • C and six (35%) had a temperature >39.5 • C. These data demonstrate that it is difficult to develop admission criteria for SCD based on fever.
The leading organism for bacteremia remained S. pneumoniae despite implementing vaccination and penicillin prophylaxis policies 16 (Supporting Information Table S2 ). [8] [9] [10] 12, [19] [20] [21] [22] [23] [24] [25] [26] [27] These data further demonstrate that bacteremia will be identified within 48 h for the overwhelming majority of febrile SCA patients. One patient in our cohort identified with bacteremia after 48 h grew Bordetella holmesii, a rare Gram-negative bacterium that has been identified as a slow growing bacteria in patients with asplenia. 17 Two prior studies identified that mean time to a positive blood culture in SCA febrile patients was 17-23 h and that 96% of cases would be identified within 48 h. 16, 18 For patients with SCA who remain febrile at 48 h but are well appearing and have negative blood cultures, a potential concern for discharge among clinicians may be the risk for patient progression to an additional sickle cell complication after discharge including development of ACS. Among the 10 febrile patients with a normal CXR in the ED that developed ACS during their hospitalization, nine required oxygen on admission and therefore were already being monitored or treated for ACS. The one patient who did not require oxygen or has an infiltrate in the ED developed an oxygen requirement on hospital day two and was diagnosed with ACS based on an abnormal CXR on day three. Therefore, prior to 48-h discharge for a well-appearing but persistently febrile patient, clinicians should perform an additional history and physical examination at the time of discharge to confirm that the patient has developed no new signs or symptoms concerning for early ACS. In our analysis of the 14-day follow-up, we identified two patients who developed ACS within 14 days of their initial ED visit for fever. One patient admitted for influenza, a known risk factor for ACS, discharged home but 8 days later developed worsening respiratory symptoms and admitted for ACS. The second patient developed ACS 11 days later. It is difficult to determine if additional inpatient therapy for the initial fever would have prevented either of these two episodes of ACS. Therefore, discharge instructions for well-appearing febrile patients must include specific education to return to the ED with any new onset cough or respiratory symptoms. Finally, our data suggest that febrile patients discharged from the ED have a low incidence of developing new SCA complications and the rate of events is similar to febrile patients admitted for <72 h. The majority of the readmission events in our cohort were due to persistent fever (62%) but a few patients (2%) did have new SCA complications. Therefore, we suggest that patients who are not ill-appearing or in respiratory distress after 48 h of inpatient hospitalization can be discharged from the hospital without a significant increased risk for new SCA complications.
When performing a retrospective review, several limitations are worth noting. First, as ED medical records from outside hospitals are not consistently included in our hospital's medical records, we excluded febrile events from an outside hospital and transferred to our inpatient unit. We also excluded patients that developed a fever during an outpatient clinic visit. The additional bacteremia events identified, most commonly among chronic transfusion patients with line infections that initially presented to our clinic without fever, may have increased our outcome numbers but were not appropriate for the primary outcome of this study, which focused on febrile events that presented to the ED. Next, among events with tachycardia defined by age-specific general pediatric sepsis heart rates, we were unable to differentiate outcomes by resolved versus persistent tachycardia after initial antipyretic therapy due to limitations in charting of time of antipyretic therapy administration. While future studies could evaluate bacteremia outcomes by response to antipyretic therapy, we did identify four bacteremic patients that had resolved fever or tachycardia in the ED with antipyretic therapy and initially discharged home.
Also, this manuscript did not include pediatric patients with HbSC or HbSB+ thalassemia as they may have a lower incidence of bacteremia than patients with HbSS or HbSB0 thalassemia. 1 Next, we could not accurately determine adherence to penicillin prophylaxis or vaccination history for this retrospective review. Finally, we did not include current SCD therapy, prior co-morbidities, or presence of a central venous line as risk factors for fever requiring admission. We acknowledge that these potential risk factors for bacteremia should be considered when individualizing admission plans; however, these potential risk factors are not included in prior febrile SCA admission criteria literature or NIH guidelines and therefore were not included in this analysis.
The lower prevalence of bacteremia in this era of antibiotic prophylaxis and vaccination hindered our ability to develop an admission criteria model that included all high-risk variables. However, institutions can utilize these data to develop institutional guidelines for febrile SCA admissions. Admitted patients with persistent fever but who are otherwise well appearing and with good oxygenation and a negative CXR can be considered for early discharge after 48-72 h as these patients demonstrated a low likelihood of developing new SCA complications in our study. Also, patients stable for discharge from the ED did not demonstrate a high prevalence of new SCA complications in the next 14 days. Individual institutions should consider their comfort with "risk" for bacteremia when developing inpatient admission and discharge criteria based on health outcomes and health economics.
Our data suggest using a model that includes ill appearance, abnormal BP, and a WBC between 20 and 30 × 10 9 /L; however, ultimately the decision to admit febrile SCD patients relies on clinical judgment and local institutional policies.
